[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2000053244A1 - Two compartment syringe - Google Patents

Two compartment syringe Download PDF

Info

Publication number
WO2000053244A1
WO2000053244A1 PCT/GB2000/000169 GB0000169W WO0053244A1 WO 2000053244 A1 WO2000053244 A1 WO 2000053244A1 GB 0000169 W GB0000169 W GB 0000169W WO 0053244 A1 WO0053244 A1 WO 0053244A1
Authority
WO
WIPO (PCT)
Prior art keywords
plunger
syringe
barrel
seal
chamber
Prior art date
Application number
PCT/GB2000/000169
Other languages
French (fr)
Inventor
Christopher John Clarke
John Targell
Alastair Douglas Wright
Original Assignee
Nmt Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nmt Group Plc filed Critical Nmt Group Plc
Priority to AU30660/00A priority Critical patent/AU3066000A/en
Publication of WO2000053244A1 publication Critical patent/WO2000053244A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31596Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing

Definitions

  • a syringe comprising a barrel having a forward end adapted to be fitted with a needle assembly, a plunger slidable within the barrel and having a plunger seal at its forward end, an annular chamber defined between the plunger and a wall surrounding the plunger, and means for establishing communication between the interior of the barrel and the annular chamber around the outer periphery of the plunger seal when the plunger is retracted.
  • the slots may extend through the barrel end giving the portion a castellated form. There may be a top seal between the rear end of the chamber and the plunger.
  • retraction of the plunger is effective to create a reduced pressure zone in the forward section of the barrel to assist transfer of one of the components to be admixed from the annular chamber to the barrel section forwardly of the plunger seal.
  • the pressure responsive one-way valve may for instance comprise a generally U-shaped seal arranged with the mouth of the seal open towards the forward direction of plunger travel and with the radially outer limb of the U-shaped seal bearing slidably against the inner wall surface of the barrel.
  • the syringe comprises a barrel 10 having a forward end 11 adapted to be fitted with a needle assembly (not shown) and preferably one such as that described in our European Patent No. 0 776 225 (the disclosure of which is incorporated herein by this reference) providing for automatic retraction of the needle into the body of the syringe at completion of administration of the injection.
  • the syringe further comprises a hollow plunger 12 which has a seal 13 at its forward end and is slidable axially within the barrel 10 between a forward position as shown in Figure 1 and a retracted position as shown in Figures 2 and 3.
  • the fully retracted position may be defined by a stop (not shown).
  • annular chamber 14 of enlarged cross-sectional area is defined between the plunger 12 and a cylindrical wall 15 surrounding the plunger 12.
  • a top seal 16 is provided between the rear end of the wall 15 and the plunger 12.
  • the wall 15 also surrounds a rearmost annular portion 17 of the barrel 10 with which the plunger seal 13 remains engaged when the plunger is fully retracted.
  • the annular portion 17 is of castellated form having circumferentially spaced axially extending slots 18.
  • the interior of the barrel 10 and annular chamber 14 define separate compartments which are pre-filled with the dry drug pellet 20 and liquid solvent or other diluent 21 respectively.
  • the pre-filled syringe is supplied with the plunger 12 substantially depressed into the barrel 10 as shown in Figure 1.
  • the plunger 12 is withdrawn as shown in Figure 2 to evacuate the interior of the barrel forwardly of the plunger and bring the seal 13 into register with the portion 17 thus providing communication via the slots 18 around the outer periphery of the seal 12 between the annular chamber 14 and that section of the barrel disposed forwardly of the plunger.
  • the solvent 21 is drawn into the barrel 10 through the slots 18 aided by the vacuum within the barrel.
  • the syringe of Figures 1 to 3 may be provided with a needle retraction mechanism for projecting the needle after use into the interior of the plunger.
  • the forward end of the plunger may be appropriately adapted, inboard of the seal 13, so as to be broken away in response to operation of the needle retraction mechanism to allow the needle to be projected into the interior of the plunger in the manner described for example in European Patent No. 0 776 225.
  • the plunger is shown in its initially depressed condition from which it must be retracted in order to transfer liquid from the section 48 to the section 46.
  • a second seal 47 fixed with respect to the barrel, is provided between the plunger and the barrel at the rear end of the barrel.
  • the seal 44 comprises a flexibly deformable cup-type washer and is of generally U-shaped configuration in cross-section with the mouth of the U opening in the forward direction of plunger travel.
  • the seal has two limbs 50, 52, one being attached to the plunger 42 and the other being arranged to bear against the inner periphery of the barrel 40.
  • the sealing afforded by seal 44 is fully effective and serves to isolate the forward section of the barrel from the rearward section.
  • plunger retraction i.e. movement to the right as viewed in Figure 4
  • the pressure in the rearward section 48 increases while the pressure in the forward section 46 decreases.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

A syringe comprises a barrel having a forward end adapted to be fitted with a needle assembly, a plunger slidable within the barrel and having a plunger seal at its forward end, and an annular chamber defined between the plunger and a wall surrounding the plunger. The interior of the barrel and the annular chamber may be pre-filled with two components which are to be admixed before administration. Retraction of the plunger is effective to establish communication between the interior of the barrel and the annular chamber to allow the pre-filled components to admix within the barrel interior. In a modification, only the annular chamber is pre-filled with a drug to be administered, the drug being transferred to a location forwardly of the plunger seal in response to plunger reaction in readiness for administration by depression of the plunger.

Description

TWO COMPARTMENT SYRINGE
This invention concerns a syringe for use with a hypodermic needle and, more particularly, one of the kind which may be pre-filled with at least one component, e.g. two components in separate compartments for admixture before administration.
Certain drugs, once in solution, have a limited shelf life requiring them to be prepared at or close to the point of use from their solid and liquid components. This is most conveniently accomplished by the provision of a pre-filled syringe which eliminates need for dispensing and measuring precise quantities from bulk supplies.
According to the present invention there is provided a syringe comprising a barrel having a forward end adapted to be fitted with a needle assembly, a plunger slidable within the barrel and having a plunger seal at its forward end, an annular chamber defined between the plunger and a wall surrounding the plunger, and means for establishing communication between the interior of the barrel and the annular chamber around the outer periphery of the plunger seal when the plunger is retracted.
A rearmost portion of the barrel may extend into the forward end of the chamber
Apertures in the rearmost portion of the barrel may be formed by circumferentially spaced axially extending slots.
The slots may extend through the barrel end giving the portion a castellated form. There may be a top seal between the rear end of the chamber and the plunger.
In one embodiment of the invention retraction of the plunger is effective to create a reduced pressure zone in the forward section of the barrel to assist transfer of one of the components to be admixed from the annular chamber to the barrel section forwardly of the plunger seal.
In a second embodiment of the invention, the means for providing communication comprises a one-way valve which may be pressure responsive.
The pressure responsive one-way valve may for instance comprise a generally U-shaped seal arranged with the mouth of the seal open towards the forward direction of plunger travel and with the radially outer limb of the U-shaped seal bearing slidably against the inner wall surface of the barrel.
The invention will now be described by way of example only with reference to the accompanying drawings, in which:
Figures 1-3 show one embodiment of the invention by way of diagrammatic axial cross-sectional views through the syringe at consecutive stages in its preparation for use; and
Figure 4 is a diagrammatic fragmentary view of a second embodiment of the invention.
Referring now to Figures 1 to 3, the syringe comprises a barrel 10 having a forward end 11 adapted to be fitted with a needle assembly (not shown) and preferably one such as that described in our European Patent No. 0 776 225 (the disclosure of which is incorporated herein by this reference) providing for automatic retraction of the needle into the body of the syringe at completion of administration of the injection. The syringe further comprises a hollow plunger 12 which has a seal 13 at its forward end and is slidable axially within the barrel 10 between a forward position as shown in Figure 1 and a retracted position as shown in Figures 2 and 3. The fully retracted position may be defined by a stop (not shown). The forward position of the plunger as shown in Figure 1 is such as to allow a drug or like component (e.g. in the form a dry slug or powder 20) to be accommodated forwardly of the plunger. During operation of the syringe, it will be understood that the plunger 12 moves further forwardly of the position illustrated in Figure 1.
An annular chamber 14 of enlarged cross-sectional area is defined between the plunger 12 and a cylindrical wall 15 surrounding the plunger 12. A top seal 16 is provided between the rear end of the wall 15 and the plunger 12. The wall 15 also surrounds a rearmost annular portion 17 of the barrel 10 with which the plunger seal 13 remains engaged when the plunger is fully retracted. The annular portion 17 is of castellated form having circumferentially spaced axially extending slots 18.
The interior of the barrel 10 and annular chamber 14 define separate compartments which are pre-filled with the dry drug pellet 20 and liquid solvent or other diluent 21 respectively. In use, the pre-filled syringe is supplied with the plunger 12 substantially depressed into the barrel 10 as shown in Figure 1. The plunger 12 is withdrawn as shown in Figure 2 to evacuate the interior of the barrel forwardly of the plunger and bring the seal 13 into register with the portion 17 thus providing communication via the slots 18 around the outer periphery of the seal 12 between the annular chamber 14 and that section of the barrel disposed forwardly of the plunger. In this way, the solvent 21 is drawn into the barrel 10 through the slots 18 aided by the vacuum within the barrel. Evacuation is possible since the interior of the barrel is sealed usually by having the sharp end of the needle when present embedded into a sealing material in a protective sheath covering the needle. The syringe may be agitated as necessary to cause the pellet 20 to be dissolved as shown in progress in Figure 3 before administering the injection in known manner.
As mentioned above, the syringe of Figures 1 to 3 may be provided with a needle retraction mechanism for projecting the needle after use into the interior of the plunger. Thus, the forward end of the plunger may be appropriately adapted, inboard of the seal 13, so as to be broken away in response to operation of the needle retraction mechanism to allow the needle to be projected into the interior of the plunger in the manner described for example in European Patent No. 0 776 225.
Referring now to the embodiment of Figure 4, this comprises a cylindrical barrel 40 in which a hollow plunger 42 is slidable, the plunger being provided with an annular seal 44 which separates the barrel interior into a sections 46 and 48 disposed forwardly and rearwardly of the seal respectively. It will be understood that the axial dimensions of the forward and rearward sections will vary in use as the plunger seal travels forwardly or rearwardly. Where two components are to be admixed in preparation for administration, the forward section 46 may accommodate one (not shown) of the components while the rearward section 48 accommodates the second component 49 which may be a liquid diluent for the first component. In Figure 4, the plunger is shown in its initially depressed condition from which it must be retracted in order to transfer liquid from the section 48 to the section 46. A second seal 47, fixed with respect to the barrel, is provided between the plunger and the barrel at the rear end of the barrel.
The seal 44 comprises a flexibly deformable cup-type washer and is of generally U-shaped configuration in cross-section with the mouth of the U opening in the forward direction of plunger travel. The seal has two limbs 50, 52, one being attached to the plunger 42 and the other being arranged to bear against the inner periphery of the barrel 40. During forward travel, it will be understood that the sealing afforded by seal 44 is fully effective and serves to isolate the forward section of the barrel from the rearward section. However, during plunger retraction (i.e. movement to the right as viewed in Figure 4), the pressure in the rearward section 48 increases while the pressure in the forward section 46 decreases. When the pressure differential reaches a certain level which will usually be predetermined by design, the seal will deform and allow the liquid in the rearward section to be drawn into the forward section ahead of the plunger seal without assistance from gravity. The plunger may be retracted until substantially all of the liquid has been transferred to forwardly of the plunger seal. In this way, the forward section is charged with the liquid from the rearward section and the liquid (if necessary after mixing/dissolution of any drug component initially located forwardly of the plunger before retraction of the latter) can then be dispensed by advancing the plunger forwardly from its retracted position.
As described in connection with the embodiment of Figures 1 to 3, the syringe of Figure 4 may also be adapted for use with a needle retraction mechanism as described for example in European Patent No. 0 776 225, the forward end of the plunger being provided with a rupturable portion for co-operation with the needle retraction mechanism in producing an access opening through which the used needle can be projected into the hollow plunger.
It will be appreciated that it is not intended to limit the invention to the above examples only, many variations, such as might readily occur to one skilled in the art, being possible, without departing from the scope thereof. Thus, for instance with reference to the embodiment of Figures 1 to 3 a dry drug need not be pre-loaded into the syringe, just a liquid drug into the chamber 14, the liquid being contained and protected from exposure to atmosphere by seals 13 and 16. Similarly in the embodiment of Figure 4, a liquid drug may be pre-loaded into the rearward section 48 for protection from exposure to atmosphere until the drug is to be administered.

Claims

1. A syringe comprising a barrel having a forward end adapted to be fitted with a needle assembly, a plunger slidable within the barrel and having a plunger seal at its forward end, an annular chamber defined between the plunger and a wall surrounding the plunger, and means for establishing communication between the interior of the barrel and the annular chamber around the outer periphery of the plunger seal when the plunger is retracted.
2. A syringe as claimed in Claim 1 in which said means comprises an aperture located so as to provide communication between the interior of the barrel and the annular chamber once the plunger has been retracted sufficiently to expose the aperture.
3. A syringe as claimed in Claim 1 in which said means comprises a one way valve.
4. A syringe as claimed in Claim 3 in which the one-way valve is pressure responsive.
5. A syringe as claimed in Claim 1 in which said means comprises a generally U-shaped seal, the mouth of the seal opening in the forward direction of plunger travel.
6. A syringe as claimed in Claim 1 in which the plunger seal constitutes said means.
7. A syringe as claimed in Claim 1, wherein a rearmost portion of the barrel extends into the forward end of the chamber
8. A syringe as claimed in Claim 7, wherein apertures in the rearmost portion of the barrel are formed by circumferentially spaced axially extending slots.
9. A syringe as claimed in Claim 8, wherein the slots extend through the barrel end giving the portion a castellated form.
10. A syringe as claimed in any one of the preceding claims, including a top seal between the rear end of the chamber and the plunger.
11. A syringe comprising a barrel, a plunger slidable in the barrel for movement between a forward position and a retracted position, an annular seal carried by the plunger for isolating a forward section of the barrel from a rearward section thereof at least during forward travel of the plunger, the forward and rearward sections of the barrel respectively forming first and second chambers, and means for establishing communication between said chambers around the outer periphery of the plunger seal during plunger retraction so as to allow transfer, in use, of a stored liquid from the second chamber to the first chamber.
12. A syringe as claimed in Claim 11 in which retraction of the plunger is effective to create a reduced pressure zone in the forward section of the barrel.
13. A syringe as claimed in Claim 11 or 12 in which the rearward section of the barrel is of increased cross-sectional area relative the forward section.
14. A syringe as claimed in Claim 13 in which the plunger seal remains in contact with a wall of the barrel throughout its travel between the forward and retracted positions, the barrel wall including at the retracted position of the plunger an apertured or slotted portion which is engaged by the plunger seal and, in part, defines the second chamber.
15. A syringe as claimed in Claim 11 in which said means comprises a generally U-shaped seal arranged with the mouth of the seal open towards the forward direction of plunger travel and with the radially outer limb of the U-shaped seal bearing slidably against the inner wall surface of the barrel.
16. A syringe as claimed in any one of Claims 11 to 15 in which the plunger is in its forward position and the second chamber contains a liquid component which is to be transferred to the first chamber on retraction of the plunger.
17. A syringe as claimed in Claim 16 in which the first chamber contains a component which is to be admixed with the liquid contained in the second chamber.
18. A syringe as claimed in any one of Claims 1 to 17 in which the plunger is hollow so as to accommodate the needle after use.
19. A syringe as claimed in Claim 18 in which the forward end of the plunger is provided with a rupturable portion located radially inboard of the plunger seal and which, when ruptured, provides access to the interior of the plunger, the syringe being provided with a needle retraction mechanism operable after use of the needle to effect rupture of said portion and projection of the needle into the plunger via the aperture created.
PCT/GB2000/000169 1999-03-09 2000-01-14 Two compartment syringe WO2000053244A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU30660/00A AU3066000A (en) 1999-03-09 2000-01-14 Two compartment syringe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9905258.1A GB9905258D0 (en) 1999-03-09 1999-03-09 Syringe for use with hypodermic needle
GB9905258.1 1999-03-09

Publications (1)

Publication Number Publication Date
WO2000053244A1 true WO2000053244A1 (en) 2000-09-14

Family

ID=10849166

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2000/000169 WO2000053244A1 (en) 1999-03-09 2000-01-14 Two compartment syringe

Country Status (3)

Country Link
AU (1) AU3066000A (en)
GB (1) GB9905258D0 (en)
WO (1) WO2000053244A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743194B2 (en) 2002-03-28 2004-06-01 Igal Sharon Multi-compartment syringe
WO2010144021A1 (en) * 2009-06-11 2010-12-16 Jan Svensson Piston and a container with such a piston
US9526846B2 (en) 2009-08-19 2016-12-27 Safety Syringes, Inc. Patient-contact activated needle stick safety device
CN114025814A (en) * 2019-05-03 2022-02-08 康尔福盛303公司 Multi-chamber syringe

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2082128A5 (en) * 1970-03-04 1971-12-10 Idees Syringe - for preserving and injecting medicaments
DE2514412A1 (en) * 1975-04-02 1976-10-14 Wimmer Pharma Gummi Gmbh Separating piston for two chamber ampoule type injection syringe - with cup-type seal permitting transfer of injection liquid but sealing on injection
US4464173A (en) * 1982-12-08 1984-08-07 Tartaglia John A Medical syringe
US4874381A (en) * 1988-02-16 1989-10-17 Arzheimittel Gmbh Apotheker Vetter & Co. Ravensburg Hypodermic syringe
EP0776225A1 (en) 1994-08-18 1997-06-04 NMT Group PLC Needle retraction mechanisms
US5779668A (en) * 1995-03-29 1998-07-14 Abbott Laboratories Syringe barrel for lyophilization, reconstitution and administration

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2082128A5 (en) * 1970-03-04 1971-12-10 Idees Syringe - for preserving and injecting medicaments
DE2514412A1 (en) * 1975-04-02 1976-10-14 Wimmer Pharma Gummi Gmbh Separating piston for two chamber ampoule type injection syringe - with cup-type seal permitting transfer of injection liquid but sealing on injection
US4464173A (en) * 1982-12-08 1984-08-07 Tartaglia John A Medical syringe
US4874381A (en) * 1988-02-16 1989-10-17 Arzheimittel Gmbh Apotheker Vetter & Co. Ravensburg Hypodermic syringe
EP0776225A1 (en) 1994-08-18 1997-06-04 NMT Group PLC Needle retraction mechanisms
US5782804A (en) * 1994-08-18 1998-07-21 Nmt Group Plc Needle retraction mechanisms
US5779668A (en) * 1995-03-29 1998-07-14 Abbott Laboratories Syringe barrel for lyophilization, reconstitution and administration

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743194B2 (en) 2002-03-28 2004-06-01 Igal Sharon Multi-compartment syringe
WO2010144021A1 (en) * 2009-06-11 2010-12-16 Jan Svensson Piston and a container with such a piston
CN102481416A (en) * 2009-06-11 2012-05-30 英特拉德拉格医疗系统公司 Piston and a container with such a piston
US9526846B2 (en) 2009-08-19 2016-12-27 Safety Syringes, Inc. Patient-contact activated needle stick safety device
US10314985B2 (en) 2009-08-19 2019-06-11 Safety Syringes, Inc. Patient-contact activated needle stick safety device
US11400234B2 (en) 2009-08-19 2022-08-02 Safety Syringes, Inc. Patient-contact activated needle stick safety device
CN114025814A (en) * 2019-05-03 2022-02-08 康尔福盛303公司 Multi-chamber syringe
CN114025814B (en) * 2019-05-03 2024-04-19 康尔福盛303公司 Multi-chamber syringe
US12280242B2 (en) 2019-05-03 2025-04-22 Carefusion 303, Inc. Multi-chamber syringe

Also Published As

Publication number Publication date
GB9905258D0 (en) 1999-04-28
AU3066000A (en) 2000-09-28

Similar Documents

Publication Publication Date Title
EP0906131B1 (en) Improvements relating to injection devices
EP2522382B1 (en) Injection device
EP1225937B1 (en) Multiple-dose syringe
JP2726906B2 (en) Injection device
EP0567483B1 (en) Subcutaneous injector
EP0072057B1 (en) Automatic injection syringe
US5300030A (en) Injection devices
EP0776225B1 (en) Needle retraction mechanisms
EP2305335B1 (en) Injection device
US6770052B2 (en) Wet/dry automatic injector assembly
KR102211531B1 (en) Drug delivery device with pneumatic power pack
EP1755707B1 (en) Injection device
EP1033143B1 (en) Device for administering a medication
US20010009990A1 (en) Device for metered administration of an injectable product
CA2338830A1 (en) Safety medical syringe with retractable needle
WO2003097133A1 (en) Injection device with automatically retractable needle
CS226001B2 (en) Syringe
CN104853787A (en) Automatic drug delivery devices
EP0856324A3 (en) Two-compartment type prefilled syringe
EP1598088B1 (en) Two chamber-type pre-filled syringe
WO2000053244A1 (en) Two compartment syringe
GB1306126A (en)
GB1149042A (en) Improvements in or relating to hypodermic injection apparatus
EP1252906A1 (en) Improved disposable pre-filled syringe
CN116782967A (en) Injection device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase